Cargando…
Glucocorticoids Inhibit EGFR Signaling Activation in Podocytes in Anti-GBM Crescentic Glomerulonephritis
Glucocorticoids are commonly used to treat anti-GBM crescentic glomerulonephritis, however, the mechanism underlying its therapeutic effectiveness is not completely understood. Since podocyte EGFR/STAT3 signaling is known to mediate the development of anti-GBM glomerulonephritis, we investigated the...
Autores principales: | Wu, Xiaomei, Ren, Lu, Yang, Qianqian, Song, Hui, Tang, Qiaoli, Zhang, Mingchao, Zhang, Jiong, Tang, Zheng, Shi, Shaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866651/ https://www.ncbi.nlm.nih.gov/pubmed/35223886 http://dx.doi.org/10.3389/fmed.2022.697443 |
Ejemplares similares
-
Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis
por: Pacheco, Mariana, et al.
Publicado: (2021) -
Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012) -
Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition
por: Sadeghi-Alavijeh, Omid, et al.
Publicado: (2018) -
Crescentic glomerulonephritis with dual positive anti-GBM and C-ANCA/PR3 antibodies
por: Omotoso, Bolanle A., et al.
Publicado: (2016) -
Educational Case: Necrotizing and Crescentic Glomerulonephritis With Anti-Glomerular Basement Membrane Antibodies (Anti-Gbm)
por: Peyton, Nicole, et al.
Publicado: (2020)